New View Surgical
Boston, US · Delaware corporation · 3 known investors
Founders & leadership
BK
Bryce KlontzExecutive
MB
Melvin B. PrenovitzNamed on SEC filing
Board
MH
Mark H. SchneiderBoard director
NB
Nancy BriefsBoard director
SF
Scott FloraBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$15.8M disclosed across 4 rounds · 2017–2022
▶$7MraisedSep 2022 · 11 investors · Other TechnologyRule 506(b)
▶$7MraisedSep 2022 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Scott FloraDirector
- Bryce KlontzExecutive Officer, Director
- Nancy BriefsDirector
- John YoungerDirector
- Melvin B. PrenovitzExecutive Officer, Director
- Mark H. SchneiderDirector
- Thomas TestaDirector
- Offering amount
- $10M
- Amount sold
- $7M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedSep 2021 · 48 investors · Other TechnologyRule 506(b)
▶$5.6MraisedSep 2021 · 48 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Bryce KlontzExecutive Officer, Director
- Mark H. SchneiderDirector
- Nancy BriefsDirector
- Melvin B. PrenovitzExecutive Officer, Director
- John YoungerDirector
- Scott FloraDirector
- Thomas TestaDirector
- Offering amount
- $9M
- Amount sold
- $5.6M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedApr 2021 · 52 investors · Other TechnologyRule 506(b)
▶$2.1MraisedApr 2021 · 52 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark H. SchneiderDirector
- Melvin B. PrenovitzExecutive Officer, Director
- Nancy BriefsDirector
- Scott FloraDirector
- Bryce KlontzExecutive Officer
- Offering amount
- $2.8M
- Amount sold
- $2.1M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedNov 2017 · 39 investors · Other TechnologyRule 506(b)
▶$1.1MraisedNov 2017 · 39 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Melvin B. PrenovitzExecutive Officer, Director
- Bryce KlontzExecutive Officer
- Arthur C. McKinleyExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $1.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapNviewmed8 shared keywordsnView medical develops the nView s1, a low-dose 3D imaging and surgical navigation system with true-map navigation and AI-based intraoperative planning, guidance, and quality control. The system is designed for pediatric and adult surgery, used by children's hospitals and surgical teams.
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Current Surgical5 shared keywordsCurrent Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.
Companies competing with New View Surgical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are New View Surgical's investors?
- New View Surgical's investors include AEON Foundry, Crimson Investment Fund, NYA 2021.
- How much funding has New View Surgical raised?
- New View Surgical has disclosed $15.8M raised across 4 rounds.
- Where is New View Surgical headquartered?
- New View Surgical is headquartered in Boston, US.